Negara: Israel
Bahasa: Inggris
Sumber: Ministry of Health
RIVAROXABAN
K.S.KIM INTERNATIONAL (SK- PHARMA) LTD., ISRAEL
B01AF01
FILM COATED TABLETS
RIVAROXABAN 2.5 MG
PER OS
Required
PHAROS – PHARMACEUTICAL ORIENTED SERVICES SINGLE MEMBER LTD, GREECE
RIVAROXABAN
Rivaroxaban S.K, co-administered with acetylsalicylic acid (ASA) alone or with ASA plus clopidogrel , is indicated for the prevention of atherothrombotic events in adult patients after an acute coronary syndrome (ACS) with elevated cardiac biomarkers.Rivaroxaban S.K,, co-administered with acetylsalicylic acid (ASA), is indicated for the prevention of atherothrombotic events in adult patients with coronary artery disease (CAD) or symptomatic peripheral artery disease (PAD) at high risk of ischaemic events.
2023-05-08
PATIENT LEAFLET IN ACCORDANCE WITH THE PHARMACISTS’ REGULATIONS (PREPARATIONS) – 1986 The medicine is dispensed with a doctor's prescription only Rivaroxaban S.K. 2.5 mg Film-coated tablets Each film-coated tablet contains: Rivaroxaban 2.5 mg For information regarding inactive ingredients: see section 2 – “Important information about some of the ingredients of the medicine” and section 6 – “Additional information”. Read the entire leaflet carefully before using the medicine. This leaflet contains concise information about the medicine. If you have additional questions, refer to the doctor or the pharmacist. This medicine has been prescribed for your treatment. Do not pass it on to others. It may harm them even if it seems to you that their medical condition is similar. 1. What is the medicine intended for? • Rivaroxaban S.K, co-administered with acetylsalicylic acid (ASA) alone or with ASA plus clopidogrel , is indicated for the prevention of atherothrombotic events in adult patients after an acute coronary syndrome (ACS) with elevated cardiac biomarkers. • Rivaroxaban S.K,, co-administered with acetylsalicylic acid (ASA), is indicated for the prevention of atherothrombotic events in adult patients with coronary artery disease (CAD) or symptomatic peripheral artery disease (PAD) at high risk of ischaemic events Therapeutic class: Rivaroxaban S.K. 2.5 mg belongs to a class of medicines called anticoagulants, and acts by reducing the tendency to produce blood clots by blocking a factor involved in the clotting process (factor Xa). 2. Before using the medicine Do not use this medicine if: Do not take Rivaroxaban S.K. 2.5 mg and inform your doctor if any of the above mentioned conditions apply to you. Special warnings regarding the use of the medicine Talk to the doctor or pharmacist before taking Rivaroxaban S.K. 2.5 mg. Do not use Rivaroxaban S.K. 2.5 mg in combination with certain drugs that reduce blood clotting such as prasugrel or ticagrelor, except for acetylsalicylic acid (aspirin) and clo Baca dokumen lengkapnya